【海王生物：2023年医疗器械营业收入突破120亿元】金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。

金融界2025-02-11

金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2510800436?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-11 20:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510800436","market":"sh","top_or_hot":-1,"title":"【海王生物：2023年医疗器械营业收入突破120亿元】金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。","media":"金融界","content":"<div>\n<p>金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/11200848088840.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【海王生物：2023年医疗器械营业收入突破120亿元】金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【海王生物：2023年医疗器械营业收入突破120亿元】金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-11 20:08 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/02/11200848088840.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/11200848088840.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159883","symbol_name":"医疗器械","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/02/11200848088840.shtml","article_id":"2510800436","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510800436","pubTimestamp":1739275718,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"159883":"医疗器械","000078":"ST海王","09996":"沛嘉医疗-B"},"translate_title":"[Neptune Bio: Medical device operating income will exceed 12 billion yuan in 2023] According to news from the financial industry on February 11, Neptune Bio's disclosure of investor relations activity records shows that the company's medical device operating income in 2023 has exceeded 12 billion yuan, and will expand the scale of the pure sales business of equipment agents, and is committed to transforming from a market agent to an enterprise with foreign brand agency rights to enhance market competitiveness. In addition, the company actively cooperates with well-known domestic suppliers to p","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"09997":1,"000078":1,"09996":1},"content_text":"金融界2月11日消息，海王生物披露投资者关系活动记录表显示，公司2023年医疗器械营业收入已突破120亿元，未来将扩大器械代理纯销业务规模，致力于从市场代理商向拥有外资品牌代理权的企业转型，提升市场竞争力。此外，公司积极与国内知名供应商合作，推动国产医疗器械的市场占有率。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2510800436","isCrawlerRequest":true}